Navigation Links
bioMerieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment
Date:11/17/2009

MARCY L'ETOILE, France, Nov. 17 /PRNewswire/ -- bioMerieux has signed an agreement with GlaxoSmithKline to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer patients. This test, based on emerging biomarkers, will be intended for use in both adjuvant and metastatic breast cancer settings, subject to regulatory approvals. Over 500,000 new cases of breast cancer are diagnosed each year in the US and Europe alone and predictive tests have been shown to improve outcomes for these patients.

"This new collaboration is a significant milestone in our theranostics strategy," said Stephane Bancel, bioMerieux Chief Executive Officer. "Working with GSK, we hope to achieve an important breakthrough in breast cancer care, helping oncologists to determine the most appropriate treatment as early as possible to give a significant number of breast cancer patients the chance for a better outcome."

The development of this new test will be co-funded by both companies and will leverage their complementary expertise. GSK, a world leader in oncology therapeutics, will bring its extensive experience in the field of cancer and conducting clinical studies and will also facilitate access to samples from several clinical trials under the collaboration.

The new test will be developed by bioMerieux's global R&D team, including its subsidiary, bioTheranostics, which has a high complexity laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). The bioTheranostics team has expertise in molecular oncology diagnostics, with its THEROS CancerTYPE ID® test for identifying metastatic cancers of uncertain or unknown origin and THEROS Breast Cancer Index(SM) test for predicting breast cancer recurrence risk.

Following clinical evaluation, the test will be launched by bioTheranostics in its CLIA-certified laboratory, after which an in vi
'/>"/>

SOURCE bioMerieux
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. bioMerieux Adds Methicillin-resistant Staphylococcus aureus (MRSA) Screening Tool to its Arsenal
2. Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting
3. Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R)
4. Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
5. Theranostics Health Receives Green Light to Perform Clinical Testing
6. Mach 7 Technologies and Data Distributing Sign Agreement for U.S. Distribution of Enterprise Image Management Solutions
7. WorldHeart Signs Agreements for Next-Generation Minimally Invasive Blood Pump
8. Misonix Announces New Distribution Agreement for Argentina
9. Millar Instruments and Transonic Systems, Suppliers of Gold Standard Pressure and Flow Products, Enter Into Mutual Distribution Agreement
10. Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE)
11. Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. ... company with a focus on Omega-3 therapies for cardiovascular ... 2015 it issued 763,752 common shares of the Corporation ... interest for the period of December 5 th , ... outstanding Convertible Notes that is due on or before ...
(Date:3/26/2015)... , March 26, 2015 "Whether it,s ... patients one day." In a single sentence, ... chief scientific officer at Pfizer,s Centers for Therapeutic ... and scientists fueling progress at America,s biopharmaceutical companies. ... work side-by-side with academia, patient foundations and the National ...
(Date:3/26/2015)... ROYAL OAK, Mich. , March 26, 2015 /PRNewswire/ ... have performed the Midwest,s first commercial implant ... Drug Administration for patients with non-valvular atrial fibrillation. The ... to long-term use of blood-thinning warfarin medication to reduce ... the most common heart rhythm disorder affecting more than ...
Breaking Medicine Technology:Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3
... Proprietary DNA delivery technology enables sustained,Interferon-beta production ... mouse model of heart disease, NEW ORLEANS--(BUSINESS ... Clinic and presented today at the American ... that a single,administration of DNA encoding the ...
... statins for only five weeks at,400 mg/week lowered ... with similarly favorable effects on other,atherogenic lipids, NEW ... Isis Pharmaceuticals, Inc. announced new,results from its Phase ... presented today at the of Cardiology,Annual Scientific Session ...
Cached Medicine Technology:Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 2Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 2Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 4Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 5Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 6Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 7Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 8Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 9
(Date:3/28/2015)... Take a bite of warm, gooey pepperoni ... tumble into the stomach, ready to break down your ... these acids run amok, triggering a burning sensation in ... than 60 million Americans have heartburn at least once ... and how it can be stopped. , Heartburn or ...
(Date:3/28/2015)... York, NY (PRWEB) March 28, 2015 ... that offers urgent care in Manhattan, recently commemorated its ... care facility in Manhattan. In addition to 24-hour urgent ... ER facilities. , At this time, Emergency Medical ... for abdominal pain, asthma, chest pain, eye injuries, ear ...
(Date:3/28/2015)... Pitching speed, player’s height, and pitching for multiple ... injuries, according to new research released today at the American ... , “Our findings indicate that a 10 inch increase in ... a history of injury, a 10 mile per hour increase ... a history of injury, and playing for more than one ...
(Date:3/28/2015)... Early surgery may not be the ... joint injuries, according to new research from Tripler Army ... Orthopaedic Society for Sports Medicine’s ( AOSSM ) Specialty ... surgery was not performed. , The final study group ... and 17 receiving non-surgical therapy. Of the non-surgery group, ...
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), a ... jobs, has announced that it will participate as ... Annual Conference to be held April 10-11, 2015 ... OH. , The OPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
Breaking Medicine News(10 mins):Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... New Medicare Regulation Protects,Texas Seniors, Access to Quality ... Texas Health Care,Association (THCA) today thanked U.S. Representatives ... (D-TX) for helping to lead a,successful, bipartisan effort ... forward with a new regulation that would that ...
... Browser Independent Access to Quantros Applications Driving ... ... provider of,hosted, Web-native safety and quality solutions for the healthcare,industry, today ... Quantros applications. Support for browsers such as,Firefox and Safari are being ...
... from Africa and Latin,America call for governments to target ... CITY, Aug. 4 A day after leaders from,the ... to,the need to combat AIDS among men who have ... exposing the failure of governments and,global health institutions to ...
... Researchers at Wake Forest University Baptist Medical Center have ... common symptoms in patients with Rett syndrome and other ... than they are in healthy individuals. The finding leaves ... anti-reflux surgery commonly performed in these children. , ...
... habit, U.S. survey shows , , MONDAY, Aug. 4 (HealthDay News) ... and regular exposure to violent movies, a new survey reveals. ... nation,s estimated 22 million children between the ages of 10 ... film, whether in theaters, on DVDs, or on television. , ...
... INDIANAPOLIS, Aug. 4 WellPoint, Inc. (NYSE: ... Bowers as president of its Senior,Business and Consumer ... role, Bowers will be responsible for leading WellPoint,s,Medicare ... is very fortunate to benefit from the unique ...
Cached Medicine News:Health News:U.S. Representatives Gohmert, Granger, E.B. Johnson Praised by THCA for Helping Lead House Effort to Stop $45.6 Million Texas Medicare Cuts 2Health News:U.S. Representatives Gohmert, Granger, E.B. Johnson Praised by THCA for Helping Lead House Effort to Stop $45.6 Million Texas Medicare Cuts 3Health News:Quantros Expanding Support for Alternative Web Browsers 2Health News:Quantros Expanding Support for Alternative Web Browsers 3Health News:As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM 2Health News:As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM 3Health News:Researchers find differences in swallowing mechanism of Rett syndrome patients 2Health News:Many Kids Under 15 Watch Violent Movies 2Health News:Many Kids Under 15 Watch Violent Movies 3Health News:WellPoint Appoints Krista A. Bowers as President of Senior Business 2
... The SEA 2000 Electrophoresis Apparatus (patented) provides ... DNA and RNA electrophoresis., In combination with ... 2000 covers applications that require a regular ... system., With the SEA 2000 it is ...
... Submerged horizontal gels offer many advantages ... a primary tool for the molecular biologist. ... readily dissipate heat. These gels allow sample ... by wicks or sample well dehydration. Horizontal ...
... The Mini-Sub cell GT system for ... acids in agarose gels includes a ... electrodes, a 7 x 7 cm ... two casting gates, and two 1.5 ...
... The DryEase Mini-Gel Drying System is a simple ... evaporation. The kit allows gels to be assembled ... both outer surfaces of the gels are exposed ... is minimized. The proprietary Gel-Dry™ Drying Solution modulates ...
Medicine Products: